Saroglitazar is used in the treatment of type 2 diabetes mellitus, noncirrhotic non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, and diabetic dyslipidemia.
How Saroglitazar works Saroglitazar contains Saroglitazar, a dual-action peroxisome proliferator-activated receptor (PPAR) inhibitor that aids in the management of high cholesterol, particularly triglycerides, as well as blood sugar levels in individuals with type 2 diabetes. It operates through a unique mechanism that reduces the synthesis and secretion of triglycerides, a type of lipid found in the blood. Additionally, it enhances the body's insulin sensitivity, leading to improved utilization of existing insulin and consequently lowering blood sugar levels.
Common side effects of Saroglitazar include weakness, fever, gastritis, and headache.
Saroglitazar 4mg

₹455.6

₹373.6
MRP ₹455.6
Saroglitazar 4mg

₹455.5

₹373.6
MRP ₹455.6
Saroglitazar 4mg

₹2,050.1

₹373.6
MRP ₹455.6
Saroglitazar 4mg

₹373.6
MRP ₹455.6
Saroglitazar 4mg

₹455.6

₹373.6
MRP ₹455.6